Unlocking protein ageing: how chromatin stands the test of time
King’s College London - 03-Feb-2025Ageing alters proteins, but chromatin remains surprisingly resilient
Join the club for FREE to access the whole archive and other member benefits.
Biomedical discovery institute dedicated to understanding the biology underlying health and disease
We are an independent organisation, established to be a UK flagship for discovery research in biomedicine. Our founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL, Imperial College London and King's College London.
The Crick was formed in 2015 and in 2017 became fully operational in our state-of-the-art building in central London, making us the biggest biomedical research facility under a single roof in Europe.
Here 1900 researchers and support staff bring together their wide-ranging knowledge and expertise to work across disciplines and explore biology at all levels, from molecules through cells to entire organisms.
Visit website: https://www.crick.ac.uk/
Details last updated 06-Sep-2019
Ageing alters proteins, but chromatin remains surprisingly resilient
Ground-breaking technology to advance the development of a bio-engineered thymus & lung disease treatments
Mutations alone are not always enough for tumour formation
Will help treat diseases due to immunodeficiency or autoimmunity
More to look forward as it promises early cancer detection when fine-tuned
Formerly Executive Vice President at AstraZeneca, Board member at Isomorphic Labs, The Francis Crick Institute, and others
Chief Executive Officer at Francis Crick Institute, winner of Nobel Prize in Physiology or Medicine
Royal Society Wolfson Fellow and Senior group leader, Francis Crick institute, London